| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4014003
[patent_doc_number] => 05880112
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-09
[patent_title] => 'Naaladase inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/833646
[patent_app_country] => US
[patent_app_date] => 1997-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10452
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/880/05880112.pdf
[firstpage_image] =>[orig_patent_app_number] => 833646
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/833646 | Naaladase inhibitors | Apr 7, 1997 | Issued |
Array
(
[id] => 3772676
[patent_doc_number] => 05807841
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-15
[patent_title] => 'HIV protease inhibitors useful for the treatment of AIDS'
[patent_app_type] => 1
[patent_app_number] => 8/825787
[patent_app_country] => US
[patent_app_date] => 1997-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12225
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/807/05807841.pdf
[firstpage_image] =>[orig_patent_app_number] => 825787
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/825787 | HIV protease inhibitors useful for the treatment of AIDS | Apr 7, 1997 | Issued |
| 08/765242 | USE OF FERROUS (III) OXYDE (FE2O3) FOR THE TREATMENT OF IMMUNE DEFICIENCIES ESPECIALLY AIDS | Apr 6, 1997 | Abandoned |
| 08/834589 | METHOD OF TREATING CANCER BY CONJUNCTIVE THERAPY WITH 2'-HALOMETHYLIDENE DERIVATIVES AND A S-PHASE OR M-PHASE SPECIFIC ANTINEOPLASTIC AGENT | Apr 6, 1997 | Abandoned |
Array
(
[id] => 4088176
[patent_doc_number] => 06017958
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-25
[patent_title] => 'Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity'
[patent_app_type] => 1
[patent_app_number] => 8/833272
[patent_app_country] => US
[patent_app_date] => 1997-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 20
[patent_no_of_words] => 22624
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/017/06017958.pdf
[firstpage_image] =>[orig_patent_app_number] => 833272
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/833272 | Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity | Apr 2, 1997 | Issued |
Array
(
[id] => 3934601
[patent_doc_number] => 05929104
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-27
[patent_title] => 'Method for inducing apoptosis of cancer cell'
[patent_app_type] => 1
[patent_app_number] => 8/829879
[patent_app_country] => US
[patent_app_date] => 1997-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 1700
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/929/05929104.pdf
[firstpage_image] =>[orig_patent_app_number] => 829879
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/829879 | Method for inducing apoptosis of cancer cell | Apr 1, 1997 | Issued |
Array
(
[id] => 3833641
[patent_doc_number] => 05814640
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-29
[patent_title] => 'Method of treating gastrointestinal malignancies'
[patent_app_type] => 1
[patent_app_number] => 8/831925
[patent_app_country] => US
[patent_app_date] => 1997-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 3515
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/814/05814640.pdf
[firstpage_image] =>[orig_patent_app_number] => 831925
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/831925 | Method of treating gastrointestinal malignancies | Apr 1, 1997 | Issued |
Array
(
[id] => 4115895
[patent_doc_number] => 06046216
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-04
[patent_title] => 'Method of treating a patient having precancerous lesions with phenyl pyridinone derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/831130
[patent_app_country] => US
[patent_app_date] => 1997-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9785
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/046/06046216.pdf
[firstpage_image] =>[orig_patent_app_number] => 831130
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/831130 | Method of treating a patient having precancerous lesions with phenyl pyridinone derivatives | Mar 31, 1997 | Issued |
Array
(
[id] => 3956187
[patent_doc_number] => 05935962
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-10
[patent_title] => 'Use of .alpha..sub.1 -adrenoreceptor antagonists in the prevention and treatment of cancer'
[patent_app_type] => 1
[patent_app_number] => 8/827137
[patent_app_country] => US
[patent_app_date] => 1997-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2015
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/935/05935962.pdf
[firstpage_image] =>[orig_patent_app_number] => 827137
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/827137 | Use of .alpha..sub.1 -adrenoreceptor antagonists in the prevention and treatment of cancer | Mar 26, 1997 | Issued |
Array
(
[id] => 4119052
[patent_doc_number] => 06071934
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-06
[patent_title] => 'Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesions'
[patent_app_type] => 1
[patent_app_number] => 8/823863
[patent_app_country] => US
[patent_app_date] => 1997-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13969
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 400
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/071/06071934.pdf
[firstpage_image] =>[orig_patent_app_number] => 823863
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/823863 | Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesions | Mar 24, 1997 | Issued |
Array
(
[id] => 4291848
[patent_doc_number] => 06235729
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-22
[patent_title] => 'Uses of phospholipase C inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/824149
[patent_app_country] => US
[patent_app_date] => 1997-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 26
[patent_no_of_words] => 15040
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/235/06235729.pdf
[firstpage_image] =>[orig_patent_app_number] => 824149
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/824149 | Uses of phospholipase C inhibitors | Mar 24, 1997 | Issued |
| 08/809563 | ANTI-TUMOR AGENTS | Mar 23, 1997 | Abandoned |
Array
(
[id] => 3762809
[patent_doc_number] => 05852057
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-22
[patent_title] => 'Anticarcinogenic drug composition'
[patent_app_type] => 1
[patent_app_number] => 8/819321
[patent_app_country] => US
[patent_app_date] => 1997-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2360
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/852/05852057.pdf
[firstpage_image] =>[orig_patent_app_number] => 819321
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/819321 | Anticarcinogenic drug composition | Mar 17, 1997 | Issued |
Array
(
[id] => 4143476
[patent_doc_number] => 06030975
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-29
[patent_title] => 'Carboxylic acid derivatives, their preparation and use in treating cancer'
[patent_app_type] => 1
[patent_app_number] => 8/818622
[patent_app_country] => US
[patent_app_date] => 1997-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23659
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 767
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/030/06030975.pdf
[firstpage_image] =>[orig_patent_app_number] => 818622
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/818622 | Carboxylic acid derivatives, their preparation and use in treating cancer | Mar 13, 1997 | Issued |
Array
(
[id] => 4041467
[patent_doc_number] => 05911985
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-15
[patent_title] => 'Pharmaceutical formulations containing a .beta.-lactamase inhibiting penem in combination with .beta.-lactam antibiotic and their use in the treatment of bacterial infections'
[patent_app_type] => 1
[patent_app_number] => 8/732379
[patent_app_country] => US
[patent_app_date] => 1997-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15542
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 233
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/911/05911985.pdf
[firstpage_image] =>[orig_patent_app_number] => 732379
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/732379 | Pharmaceutical formulations containing a .beta.-lactamase inhibiting penem in combination with .beta.-lactam antibiotic and their use in the treatment of bacterial infections | Mar 13, 1997 | Issued |
Array
(
[id] => 4155991
[patent_doc_number] => 06103698
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-15
[patent_title] => 'Dolastatin-15 derivatives in combination with taxanes'
[patent_app_type] => 1
[patent_app_number] => 8/819101
[patent_app_country] => US
[patent_app_date] => 1997-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14978
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 864
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/103/06103698.pdf
[firstpage_image] =>[orig_patent_app_number] => 819101
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/819101 | Dolastatin-15 derivatives in combination with taxanes | Mar 12, 1997 | Issued |
| 08/816411 | COMPOSITION AND METHOD FOR TREATING PROSTATE CANCER | Mar 12, 1997 | Abandoned |
Array
(
[id] => 3783419
[patent_doc_number] => 05821245
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-13
[patent_title] => 'Use of naphthalene derivatives in treating lung carcinoma'
[patent_app_type] => 1
[patent_app_number] => 8/815671
[patent_app_country] => US
[patent_app_date] => 1997-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21123
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 278
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/821/05821245.pdf
[firstpage_image] =>[orig_patent_app_number] => 815671
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/815671 | Use of naphthalene derivatives in treating lung carcinoma | Mar 12, 1997 | Issued |
Array
(
[id] => 3770197
[patent_doc_number] => 05733904
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-31
[patent_title] => 'Method for prevention and treatment of viral infectious diseases for viral suppression'
[patent_app_type] => 1
[patent_app_number] => 8/815669
[patent_app_country] => US
[patent_app_date] => 1997-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6399
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/733/05733904.pdf
[firstpage_image] =>[orig_patent_app_number] => 815669
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/815669 | Method for prevention and treatment of viral infectious diseases for viral suppression | Mar 9, 1997 | Issued |
Array
(
[id] => 4186347
[patent_doc_number] => 06160018
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-12
[patent_title] => 'Prophylactic composition and method for alzheimer\'s Disease'
[patent_app_type] => 1
[patent_app_number] => 8/814490
[patent_app_country] => US
[patent_app_date] => 1997-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5870
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/160/06160018.pdf
[firstpage_image] =>[orig_patent_app_number] => 814490
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/814490 | Prophylactic composition and method for alzheimer's Disease | Mar 9, 1997 | Issued |